Powered by
DETROIT–The Barbara Ann Karmanos Cancer Institute, a National Cancer Institute-Designated Comprehensive Cancer Center, has become the first cancer center to receive the SoftVue 3D Whole Breast Ultrasound Tomography System following …
ANN ARBOR–HistoSonics Inc., the developer and manufacturer of a completely non-invasive platform and proprietary sonic beam therapy, announced the publication of results from their prospective Phase I clinical trial, conducted …
ANN ARBOR—Strata Oncology Inc., developers of novel cancer treatment, announced that Lehigh Valley Topper Cancer Institute and the University of Michigan Health Rogel Cancer Center have joined as clinical trial sites …
ROYAL OAK—Immunis.AI Inc., a biotech company developing noninvasive blood-based tests for disease, announced the publication of pivotal results from its clinical trial, Evaluation of an RNAseq-based Immunogenomic Liquid Biopsy Approach …
NOVI—Officials at Delphinus Medical Technologies Inc. announced that the U.S. Food and Drug Administration has granted premarket approval of its SoftVue 3D Whole Breast Ultrasound Tomography System. The system is …
ANN ARBOR—HistoSonics, developer of a non-invasive sonic beam therapy, announced today the treatment of the first patient in the #HOPE4LIVER US Study. The investigational device study was approved by the …
DETROIT—Henry Ford Health System and Michigan State University have announced a 30-year partnership to make Michigan a national leader in providing access to exceptional health care for all residents, scientific discovery and …
LOS ANGELES—Officials at the St. Baldrick’s Foundation has named two Michigan hospitals among 17 grant winners of $819,000 in grants to advance research into children’s cancers. The Los Angeles-based foundation …
DETROIT—Officials at the Karmanos Cancer Institute in Detroit have announced the launch of a new clinical trials study information portal (SIP) at www.karmanos.org/opentrials. The SIP website, which is integrated with …
DETROIT—Officials at the Barbara Ann Karmanos Cancer Institute announced that its National Cancer Institute (NCI) Core Grant has been renewed. This renewal extends Karmanos’ prestigious NCI designation through 2025, making …